Maravai Lifesciences Holdings annual debt-to-equity ratio
2020
2021
2022
2023
2024
2025
Maravai Lifesciences Holdings Debt-to-Equity Ratio Growth & History (MRVI)
Maravai Lifesciences Holdings's debt-to-equity ratio was 1.72 for fiscal 2025.
View full Maravai Lifesciences Holdings company overviewMaravai Lifesciences Holdings annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.72 | 0.56 | +48.29% |
| 2024 | 2024-12-31 | 1.16 | −0.31 | −21.01% |
| 2023 | 2023-12-31 | 1.47 | 0.39 | +36.57% |
| 2022 | 2022-12-31 | 1.07 | −0.75 | −41.12% |
| 2021 | 2021-12-31 | 1.82 | −4.85 | −72.68% |
| 2020 | 2020-12-31 | 6.67 | — | — |
Maravai Lifesciences Holdings quarterly debt-to-equity ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.86 | −0.53 | −38.13% |
| Q1 2026 | 2026-03-31 | 1.28 | 0.19 | +17.83% |
| Q4 2025 | 2025-12-31 | 1.72 | 0.56 | +48.29% |
| Q3 2025 | 2025-09-30 | 1.50 | −0.13 | −7.85% |
| Q2 2025 | 2025-06-30 | 1.40 | 0.10 | +7.99% |
| Q1 2025 | 2025-03-31 | 1.09 | −0.28 | −20.70% |
| Q4 2024 | 2024-12-31 | 1.16 | −0.31 | −21.01% |
| Q3 2024 | 2024-09-30 | 1.63 | 0.44 | +37.43% |
| Q2 2024 | 2024-06-30 | 1.29 | 0.11 | +9.00% |
| Q1 2024 | 2024-03-31 | 1.37 | 0.21 | +18.35% |
| Q4 2023 | 2023-12-31 | 1.47 | 0.39 | +36.57% |
| Q3 2023 | 2023-09-30 | 1.18 | 0.04 | +3.19% |
| Q2 2023 | 2023-06-30 | 1.19 | 0.02 | +1.50% |
| Q1 2023 | 2023-03-31 | 1.16 | −0.23 | −16.42% |
| Q4 2022 | 2022-12-31 | 1.07 | −0.75 | −41.12% |
| Q3 2022 | 2022-09-30 | 1.15 | −0.80 | −40.97% |
| Q2 2022 | 2022-06-30 | 1.17 | −1.87 | −61.56% |
| Q1 2022 | 2022-03-31 | 1.39 | −3.86 | −73.58% |
| Q4 2021 | 2021-12-31 | 1.82 | −4.85 | −72.68% |
| Q3 2021 | 2021-09-30 | 1.94 | — | — |
| Q2 2021 | 2021-06-30 | 3.04 | — | — |
| Q1 2021 | 2021-03-31 | 5.24 | — | — |
| Q4 2020 | 2020-12-31 | 6.67 | — | — |
Maravai Lifesciences Holdings debt-to-equity ratio trends
Over the last five fiscal years, Maravai Lifesciences Holdings's debt-to-equity ratio decreased from 6.67 to 1.72, a change of −4.96. The latest reported quarter, Q2 2026, shows 0.86.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Maravai Lifesciences Holdings source filings ↗